Injectable treatment just as effective as standard HIV combination in Africa

 Professor Nicholas Paton of the London School of Hygiene and Tropical Medicine reported on Monday at the ,,,

,,, Conference on Retroviruses and Opportunistic Infections (CROI 2024) in Denver that injectable treatment   

 with cabotegravir and rilpivirine proved to be just as effective in maintaining viral suppression as standard oral antiretroviral treatment in a large trial in Africa.  

 This was despite the fact that the viral load monitoring was less intensive than in previous studies. 

 As far as the continent of Africa is concerned, this trial is the first test of injectable therapy in HIV patients.  

 Both Europe and North America have already given their approval for the use of the first injectable regimen,,,

 During the course of treatment, an intramuscular injection is administered at a medical facility once every two months.  

 Before injectable treatment with cabotegravir and rilpivirine can be made available through treatment programs in Africa.

5 Zodiac Signs With Powerful Horoscopes On February 25, 2024